Synaptogenix Total Assets from 2010 to 2025

SNPX Stock  USD 2.84  0.06  2.07%   
Synaptogenix Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets will likely drop to about 28.6 M in 2025. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
 
Total Assets  
First Reported
2010-12-31
Previous Quarter
35.8 M
Current Value
28.6 M
Quarterly Volatility
8.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Synaptogenix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Synaptogenix's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 1.8 M or Interest Income of 1.8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.19 or PTB Ratio of 0.14. Synaptogenix financial statements analysis is a perfect complement when working with Synaptogenix Valuation or Volatility modules.
  
Check out the analysis of Synaptogenix Correlation against competitors.
For more information on how to buy Synaptogenix Stock please use our How to Invest in Synaptogenix guide.

Latest Synaptogenix's Total Assets Growth Pattern

Below is the plot of the Total Assets of Synaptogenix over the last few years. Total assets refers to the total amount of Synaptogenix assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Synaptogenix books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Synaptogenix's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Synaptogenix's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 31.11 M10 Years Trend
Slightly volatile
   Total Assets   
6.8M35.5M38.6M31.1M35.8M28.6M426%9%-19%15%-20%100%
       Timeline  

Synaptogenix Total Assets Regression Statistics

Arithmetic Mean22,208,309
Geometric Mean20,526,948
Coefficient Of Variation39.85
Mean Deviation7,320,274
Median17,897,821
Standard Deviation8,850,893
Sample Variance78.3T
Range31.9M
R-Value0.63
Mean Square Error51T
R-Squared0.39
Significance0.01
Slope1,164,826
Total Sum of Squares1175.1T

Synaptogenix Total Assets History

202528.6 M
202435.8 M
202331.1 M
202238.6 M
202135.5 M
20206.8 M

Other Fundumenentals of Synaptogenix

Synaptogenix Total Assets component correlations

About Synaptogenix Financial Statements

Synaptogenix investors use historical fundamental indicators, such as Synaptogenix's Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Synaptogenix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Assets35.8 M28.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Synaptogenix Stock Analysis

When running Synaptogenix's price analysis, check to measure Synaptogenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synaptogenix is operating at the current time. Most of Synaptogenix's value examination focuses on studying past and present price action to predict the probability of Synaptogenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synaptogenix's price. Additionally, you may evaluate how the addition of Synaptogenix to your portfolios can decrease your overall portfolio volatility.

Trending Assets

CYTH
Cyclo Therapeutics
0.89  -0.06  -6.32 
ALZN
Alzamend Neuro
0.96  -0.06  -5.88 
RVPH
Reviva Pharmaceuticals
1.56  -0.07  -4.29 
ANVS
Annovis Bio
2.13  -0.1  -4.48 
INMB
INmune Bio
8.59  -0.9  -9.48 
News Freq…Investor S…